1 Influenza |
25 |
71221 |
Risk Ratio (M‐H, Random, 95% CI) |
0.41 [0.36, 0.47] |
1.1 WHO recommended ‐ matching vaccine |
15 |
46444 |
Risk Ratio (M‐H, Random, 95% CI) |
0.41 [0.34, 0.49] |
1.2 WHO recommended ‐ vaccine matching absent or unknown |
7 |
15068 |
Risk Ratio (M‐H, Random, 95% CI) |
0.45 [0.34, 0.59] |
1.3 Monovalent not WHO recommended ‐ vaccine matching |
2 |
9675 |
Risk Ratio (M‐H, Random, 95% CI) |
0.22 [0.10, 0.52] |
1.4 Monovalent not WHO recommended ‐ vaccine matching ‐ high dose |
1 |
34 |
Risk Ratio (M‐H, Random, 95% CI) |
0.11 [0.00, 2.49] |
2 Influenza‐like illness |
16 |
25795 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.75, 0.95] |
2.1 WHO recommended ‐ matching vaccine |
7 |
4760 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.77, 0.91] |
2.2 WHO recommended ‐ vaccine matching absent or unknown |
7 |
20942 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.69, 1.18] |
2.3 Monovalent not WHO recommended ‐ vaccine matching |
1 |
59 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.28, 3.70] |
2.4 Monovalent not WHO recommended ‐ vaccine matching ‐ high dose |
1 |
34 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.09, 2.30] |
3 Physician visits |
2 |
2308 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.40, 1.89] |
3.1 WHO recommended ‐ matching vaccine |
1 |
1178 |
Risk Ratio (M‐H, Random, 95% CI) |
0.58 [0.37, 0.91] |
3.2 WHO recommended ‐ vaccine matching absent or unknown |
1 |
1130 |
Risk Ratio (M‐H, Random, 95% CI) |
1.28 [0.90, 1.83] |
4 Days ill |
3 |
3133 |
Mean Difference (IV, Random, 95% CI) |
‐0.21 [‐0.98, 0.56] |
4.1 WHO recommended ‐ matching vaccine |
2 |
2003 |
Mean Difference (IV, Random, 95% CI) |
‐0.58 [‐0.85, ‐0.32] |
4.2 WHO recommended ‐ matching absent or unknown |
1 |
1130 |
Mean Difference (IV, Random, 95% CI) |
0.66 [0.16, 1.16] |
5 Times any drugs were prescribed |
2 |
2308 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.03, 0.01] |
5.1 WHO recommended ‐ matching vaccine |
1 |
1178 |
Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.04, ‐0.00] |
5.2 WHO recommended ‐ matching absent or unknown |
1 |
1130 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐0.00, 0.00] |
6 Times antibiotic was prescribed |
2 |
2308 |
Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.03, ‐0.01] |
6.1 WHO recommended ‐ matching vaccine |
1 |
1178 |
Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.03, ‐0.01] |
6.2 WHO recommended ‐ matching absent or unknown |
1 |
1130 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.03, 0.01] |
7 Working days lost |
4 |
3726 |
Mean Difference (IV, Random, 95% CI) |
‐0.04 [‐0.14, 0.06] |
7.1 WHO recommended ‐ matching vaccine |
3 |
2596 |
Mean Difference (IV, Random, 95% CI) |
‐0.09 [‐0.19, 0.02] |
7.2 WHO recommended ‐ matching absent or unknown |
1 |
1130 |
Mean Difference (IV, Random, 95% CI) |
0.09 [0.00, 0.18] |
8 Hospitalisations |
3 |
11924 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.85, 1.08] |
8.1 WHO recommended ‐ matching vaccine |
1 |
1178 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.2 WHO recommended ‐ vaccine matching absent or unknown |
1 |
1130 |
Risk Ratio (M‐H, Random, 95% CI) |
2.89 [0.12, 70.68] |
8.3 Monovalent not WHO recommended ‐ vaccine matching |
1 |
9616 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.85, 1.08] |
9 Clinical cases (clinically defined without clear definition) |
3 |
4259 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.72, 1.05] |
9.1 WHO recommended ‐ matching vaccine |
2 |
2056 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.64, 1.25] |
9.2 WHO recommended ‐ vaccine matching absent or unknown |
1 |
2203 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.69, 0.99] |
10 Local harms |
20 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
10.1 Local ‐ tenderness/soreness |
20 |
35655 |
Risk Ratio (M‐H, Random, 95% CI) |
3.13 [2.44, 4.02] |
10.2 Local ‐ erythema |
9 |
29499 |
Risk Ratio (M‐H, Random, 95% CI) |
2.59 [1.77, 3.78] |
10.3 Local ‐ induration |
3 |
7786 |
Risk Ratio (M‐H, Random, 95% CI) |
4.28 [1.25, 14.67] |
10.4 Local ‐ arm stiffness |
1 |
50 |
Risk Ratio (M‐H, Random, 95% CI) |
1.62 [0.54, 4.83] |
10.5 Local ‐ combined endpoint (any or highest symptom) |
11 |
12307 |
Risk Ratio (M‐H, Random, 95% CI) |
2.44 [1.82, 3.28] |
11 Systemic harms |
17 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
11.1 Systemic ‐ myalgia |
11 |
35008 |
Risk Ratio (M‐H, Random, 95% CI) |
1.74 [1.41, 2.14] |
11.2 Systemic ‐ fever |
13 |
23850 |
Risk Ratio (M‐H, Random, 95% CI) |
1.55 [1.26, 1.91] |
11.3 Systemic ‐ headache |
14 |
35999 |
Risk Ratio (M‐H, Random, 95% CI) |
1.14 [0.99, 1.30] |
11.4 Systemic ‐ fatigue or indisposition |
12 |
35788 |
Risk Ratio (M‐H, Random, 95% CI) |
1.19 [1.05, 1.36] |
11.5 Systemic ‐ nausea/vomiting |
4 |
6315 |
Risk Ratio (M‐H, Random, 95% CI) |
1.80 [0.65, 5.04] |
11.6 Systemic ‐ malaise |
3 |
26111 |
Risk Ratio (M‐H, Random, 95% CI) |
1.51 [1.18, 1.92] |
11.7 Systemic ‐ combined endpoint (any or highest symptom) |
6 |
2128 |
Risk Ratio (M‐H, Random, 95% CI) |
1.16 [0.87, 1.53] |